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Abstract: Accurate photodynamic therapy (PDT) dosimetry is critical for the use of PDT in the
treatment of malignant and nonmalignant localized diseases. A singlet oxygen explicit dosimetry
(SOED) model has been developed for in vivo purposes. It involves the measurement of the key
components in PDT—light fluence (rate), photosensitizer concentration, and ground-state oxygen
concentration ([3O2])—to calculate the amount of reacted singlet oxygen ([1O2]rx), the main cytotoxic
component in type II PDT. Experiments were performed in phantoms with the photosensitizer
Photofrin and in solution using phosphorescence-based singlet oxygen luminescence dosimetry
(SOLD) to validate the SOED model. Oxygen concentration and photosensitizer photobleaching
versus time were measured during PDT, along with direct SOLD measurements of singlet oxygen and
triplet state lifetime (τ∆ and τt), for various photosensitizer concentrations to determine necessary
photophysical parameters. SOLD-determined cumulative [1O2]rx was compared to SOED-calculated
[1O2]rx for various photosensitizer concentrations to show a clear correlation between the two
methods. This illustrates that explicit dosimetry can be used when phosphorescence-based dosimetry
is not feasible. Using SOED modeling, we have also shown evidence that SOLD-measured [1O2]rx
using a 523 nm pulsed laser can be used to correlate to singlet oxygen generated by a 630 nm laser
during a clinical malignant pleural mesothelioma (MPM) PDT protocol by using a conversion formula.
Keywords: photodynamic therapy; singlet oxygen explicit dosimetry (SOED); singlet oxygen
luminescence dosimetry (SOLD); Photofrin; oxygen
1. Introduction
Photodynamic therapy (PDT) is an evolving treatment modality for many cancers such as
microinvasive lung cancer, obstructing lung cancer, and obstructing esophageal cancer, for premalignant
diseases such as actinic keratosis, and non-oncologic conditions such as age-related macular
degeneration [1–3]. PDT is advantageous for its low systemic toxicity, lack of induced resistance,
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repeatability, and preservation of normal tissue structure. Widespread use of PDT has been restricted
by the difficulty in accurately quantifying the effective treatment dose. PDT is dynamic and
multifaceted, with complex and dynamic interactions between treatment light at a particular
wavelength, photosensitizer (PS), and tissue oxygen ([3O2]) [3]. In a typical photodynamic process, the
photosensitizer is excited by the treatment light and enters the excited singlet state. This singlet state
undergoes intersystem crossing to the triplet state. This triplet state can react directly with molecular
substrates or transfer a hydrogen atom or an electron to 3O2 to produce radicals or radical ions in
a type I process [4]. Most clinically relevant photosensitizers undergo type II processes in which the
triplet state transfers energy to ground-state oxygen, 3O2, to produce singlet oxygen, 1O2 [4], which is
the main photocytotoxic agent leading to cell death and therapeutic response [5,6].
PDT dosimetry has so far involved the prescription of an administered drug dose and a light
fluence (energy per unit area). This is often inadequate due to the variation in photosensitizer
localization from patient to patient as well as within the tumor environment [7,8]. Furthermore,
tissue and blood oxygenation are key components for PDT and will affect not only the production
of 1O2 but also the tissue optical properties [9,10]. In turn, the penetration of light is dependent on
the tissue optical properties [11]. Simplistically, PDT dose may be defined as the time integral of the
photosensitizer concentration and the light fluence. However, this does not take into account the effect
of tissue hypoxia. In a hypoxic environment, the production of 1O2 will be lower than expected and
treatment outcome will not be predictable [7,8].
For these compelling reasons, the use of singlet oxygen concentration, [1O2] as the dosimetric
measure has been suggested. Direct measurement of 1O2 by its near-infrared luminescence emission
is technically challenging in vivo due to the weakness of the signal and the short lifetime of 1O2,
~30–180 ns [12,13]. Hence, a macroscopic singlet oxygen explicit dosimetry (SOED) model has been
previously developed and studied for various sensitizers in vivo [8,14–16]. In the present work,
SOED was compared in solutions to direct singlet oxygen luminescence dosimetry (SOLD) [17,18].
The relevant photophysical parameters for the macroscopic model were verified by performing
explicit dosimetry of oxygen concentration and photosensitizer concentration. In performing a direct
comparison between SOED- and SOLD-measured 1O2, the use of SOED in scenarios where direct
luminescence detection is difficult is validated. Furthermore, an analysis is provided to show that
SOLD measured using a 523 nm pulsed laser (currently required by the availability of lasers with
suitable pulse length, repetition frequency, and energy) is well-correlated to singlet oxygen generated
by Photofrin by a CW 630 nm laser during PDT, by correcting for the tissue optical properties at the
two wavelengths.
2. Materials and Methods
2.1. SOED Model In Vitro and In Vivo
Singlet oxygen produced during illumination was calculated using an explicit dosimetry model.
Based on type II processes modeled, a set of coupled differential equations has been established for the
photophysical reactions [8,16,19].
A set of simplified differential equations that are valid over time scales of a few seconds to
hours can be used to describe the interactions of singlet oxygen concentration, [1O2], photosensitizer
concentration, [S0], the ground-state oxygen concentration, [3O2], and the reacted singlet oxygen
concentration, [1O2]rx for the in vitro scenario with parameters (and ki) defined in Table 1 (and its
footnote) [19]:
[1O2] = ξτ∆
[3O2]
[3O2] + β
φ[S0]
1
(σ([S0] + δ) + 1)
(1)
d[S0]
dt
= −ξ [
3O2]
[3O2] + β
φ[S0]
(
σ([S0] + δ)
(σ([S0] + δ) + 1)
)
(2)
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d[3O2]
dt
= −ξ [
3O2]
[3O2] + β
φ[S0]
(
σ([S0] + δ) + k7[A]τ∆
(σ([S0] + δ) + 1)
)
(3)
[1O2]rx =
w
ξ
[3O2]
[3O2] + β
φ[S0]
1
(σ([S0] + δ) + 1)
dt (4)
where σ = k1/(k6 + k7[A]), ξ = Φ∆(ε/hν), τ∆−1 = k6 + k7[A], and β = k4/k2. Here, Φ∆ is the singlet
oxygen quantum yield in the aqueous Intralipid medium. The parameters used for the calculation
for each phantom are summarized in Table 1. For studies without NaN3, the 1O2 quencher used in
solutions, [A] = 0. For the in vivo scenario, Equations (2) and (3) can be rewritten as [8,14–16,20]:
d[S0]
dt
= −ξ [
3O2]
[3O2] + β
φ[S0]σ([S0] + δ) (5)
d[3O2]
dt
= −
(
ξ
φ[S0]
[3O2] + β
)
[3O2] + g
(
1− [
3O2]
[3O2](t = 0)
)
(6)
where we assumed that σ([S0] + δ) << 1. Here we have added an oxygen perfusion term to account for
vasculature in vivo, and the value of g = 0.7 µM/s for Photofrin.
Equation (5) can be rewritten as the following:
− d[S0]
dt
/φ[S0]
[3O2]
[3O2] + β
= ξσ([S0] + δ) (7)
The left-hand side of Equation (7) versus [S0](t) gives the values of δ and σ used in Table 1.
The photobleaching rate (−d[S0]/dt) was determined at each time point, along with the values of
φ, [3O2], [S0], and β for the calculation of the left-hand side of Equation (7). A linear fit to the data
yields a value for the intercept and slope, and the intercept divided by the slope gives δ and the slope
divided by ξ gives σ. A recent review lists known values for in vivo photophysical parameters for
many photosensitizers used clinically [19]. The SOED-calculated solutions were compared with the
oxygen and [S0](t) concentrations. All calculations were performed using Matlab 2014b (MathWorks,
Natick, MA, USA).
2.2. SOLD Instrumentation
Singlet oxygen luminescence dosimetry (SOLD) was performed using a compact, fiberoptic
near-infrared probe-based system [21,22]. The probe was coupled to a compact InGaAs/InP single
photon avalanche diode (SPAD) detector (Micro Photon Devices, Bolzano Italy). Samples were
illuminated with a 523 nm wavelength pulsed laser (QL-523-200-S, CrystaLaser, Reno, NV, USA)
coupled into the delivery fiber via a collimation package. Patterned time gating was used to limit
the unwanted dark counts and eliminate the strong photosensitizer luminescence background.
The luminescence signal from singlet oxygen at 1270 nm was confirmed through spectral filtering and
lifetime fitting for Photofrin.
Figure 1 shows a photograph and schematic of the experimental setup. The pulsed laser was
coupled into the delivery fiber. The laser also outputs an electrical signal that is sent to a programmable
pulse pattern generator (PPG) (Agilent 81110A, Keysight Technologies, Inc., Santa Rosa, CA, USA).
Each pulse generates outputs on two separate channels, each with pulse shape designed to match the
intended input. The first output is a single pulse sent to the “start” channel of the time-correlated
single-photon counting (TCSPC) module (HydraHarp, PicoQuant GmbH, Berlin, Germany), while the
second is a pattern of pulses sent to the SPAD control module. The SPAD is turned on for a preassigned
time, only when the control module receives a pulse from the PPG.
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Figure 1. Singlet oxygen lu inescence dosi etry (SOLD) instru entation setup (a) on an optical
bench; and (b) schematic diagram of the experimental arrangement. PPG pulse pattern generator;
SPAD single photon avalanche diode; TCSPC time-correlated single-photon counting.
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by subtracting the histogram taken through a 1210 nm filter from t at through the
1270 nm filter. Equation (8) describes the [1O2] signal as a function f time following a sh rt
illumination pulse.
[1O2](t) = NσA[S0]Φ∆
τ∆
τt − τ∆
(
e−t/τt − −t/τ∆
)
(8)
The cumulative SOLD singlet oxygen count can be calculated as the integral of Equation (8)
per τR [23].
∞w
0
1
τR
[1O2](t)dt =
NσA[S0]Φ∆τ∆
τR
(9)
where N is the number of photons in the illumination pulse, σA is the PS absorption cross-section
(σA = (ε/NA) × 109), NA is Avogadro’s constant (6.02 × 1023), ε is the extinction coefficient, and τR is
the 1O2 phosphorescence lifetime (k6−1). A fit of the background-subtracted histograms was performed
to Equation (8) (with a y-axis offset as a free parameter to account for any change in the background
level) using Origin software with a Levenberg–Marquardt algorithm to iterate the parameter values.
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2.3. Measurements in Tissue-Simulating Phantoms
Explicit dosimetry of phantom studies was performed using tissue-simulating liquid phantoms.
A lipoprotein colloidal suspension, Intralipid (Fresenius Kabi, Uppsala, Sweden) was added to
solutions to provide optical scattering. A broad beam (0.4 cm radius) was produced by a fiber with
a microlens attachment (Pioneer Optics Company, Bloomfield, CT, USA) onto the side of cuvette
phantoms. Oxygen measurements were made with a bare-fiber OxyLite probe (Oxford Optronix,
Oxford, UK) on the side closest to beam entry at the center of the field. In the in vitro setup, there is
very little oxygen diffusion at the point of measurement, so that oxygen measurements were performed
with brief interruptions of the excitation laser at 1–30 s intervals. The oxygen partial pressure was
measured in mmHg and converted to µM by using a factor of α = 1.3 [14,24]. PS concentration was
determined by obtaining fluorescence spectra produced by Photofrin excited by the treatment light.
Spectral analysis was performed using single value decomposition fitting of the characteristic Photofrin
peak [25].
2.4. Comparison of 630 nm and 523 nm SOED
Optical properties from multiple sites of several different patients undergoing treatment for
pleural-PDT were determined from absorption spectra using a white light source (Avantes, Little Rock,
AK, USA) connected to a multifiber contact probe, as described elsewhere [26,27]. The multifiber probe
has a source fiber attached to a halogen white light source. This was used to obtain broadband reflectance
at multiple source-detector separations. The diffusion equation was used to determine the solution for
diffuse reflectance for a semi-infinite medium with steady-state excitation. The longitudinal distribution
of φ for different tissue optical properties was determined using an analytical formula [28] based on
Monte Carlo simulations [29–32]. To obtain the corresponding temporal changes of [S0] and [3O2],
the information of φ distribution, the magnitude of the Photofrin-specific reaction-rate parameters,
and the measured photosensitizer concentrations [33] were passed to the time (t)-dependent differential
Equations (5) and (6) for a given treatment time point, which were then used to calculate [1O2]rx using
Equation (4).
3. Results
3.1. SOED Photophysical Parameters
Photophysical parameter values for Photofrin were determined for in vitro macroscopic modeling
from the literature as well as measurements to be used in the calculation of [1O2]rx. These parameters
are listed in Table 1. Figure 2 shows the SOLD measurement of singlet oxygen lifetime as a function of
the concentration of added sodium azide (NaN3), which is a potent singlet oxygen-specific quencher,
for Photofrin in MeOH solution. The intercept of the linear fit (solid line in Figure 2) corresponds to k6
and the slope corresponds to the value for k7.
Cancers 2016, 8, 109 6 of 15
Table 1. Summary of photophysical parameters for Photofrin in vitro and in vivo.
Parameter Definition In Vitro In Vivo
ε (cm−1·µM−1) Photosensitizer extinction coefficient 0.0035 at 632 nm
(1)
0.0089 at 523 nm (1)
β (µM) Oxygen-quenching threshold concentration k4k2 * 11.9 [34]
δ (µM) Low-concentration correction 25 ± 4.3 (2) 33 [15]
ξ (cm2·mW−1·s−1) Specific oxygen consumption rate ξ = Φ∆ εhν
10.3 × 10−3 (3)
at 632 nm
24.8 × 10−3 (4)
at 523 nm
3.7 × 10−3 [34]
at 632 nm
8.99 × 10−3 (5)
at 523 nm
σ (µM−1) Specific photobleaching ratio where σ = k1τ∆ * (6.6 ± 7) × 10−5 (2) 7.6 × 10−5 [8,34]
τ∆ (s) Singlet oxygen lifetime
1
k6+k7[A]
* (9.4 ± 0.2) × 10−6 (6) 1.6 × 10−7 [35]
τt (s) Triplet state lifetime
1
k4+k2[3O2]
* (0.43 ± 0.03) × 10−6 (7) 1.5 × 10−6 (7)
Φ∆ Singlet oxygen quantum yield 0.56 [36,37] 0.20 [19]
(1) Measured from absorption spectroscopy; (2) Obtained from fitting shown in Figure 3c using Equation (7);
(3) Calculated using Φ∆ = 0.56 in water, ε = 0.0035 cm−1·µM−1, and hν = 3.2 × 10−16 mWs at 632 nm;
(4) Calculated using Φ∆ = 0.64 in MeOH, ε = 0.0089 cm−1·µM−1, and hν = 3.8 × 10−16 mWs at 523 nm;
(5) Scaled in vivo value at 632 nm by ε(at 523 nm)/ε(at 632 nm); (6) Measured values from SOLD experiment
when [A] = 0 (i.e., without NaN3 in MeOH solution); (7) Calculated from measured data using [3O2] = 40 µM for
in vivo conditions and [3O2] = 169 µM for in vitro conditions. Thereby, τt in vivo was estimated by determining
k2 in vitro (1.3 × 104 µM−1·s−1) and using β = k4/k2 = 11.9 µM and 1/τt = k2(β + [3O2]); * The definition of
the photophysical parameters are [19]: k1 = rate of photosensitizer (PS) photobleaching; k2 = rate of triplet PS
quenching by 3O2; k4 = decay rate of triplet PS without 3O2; k6 = rate of 1O2 phosphorescence decay; k7 = rate of
1O2 quenching by substrate.
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Figure 2. Singlet oxygen lifetime (τ∆) changes due to quenching with various concentrations of sodium
azide (NaN3) for Photofrin (50 µM) in MeOH, τ∆−1 = k6 + k7[A]. Symbols represent measured data
and the solid line is the best linear fit.
3.2. SOED in Phantom
hotofrin phantoms with Intralipid as optical scatterer a d absorption due to both the
photosensitizer and water (or Intralipid) were used to measure the time dependence of [3O2] and
PS concentration, [S0], under CW 630 nm laser excitation. [3O2](t) was measured using an oxygen
phosphorescence probe and the photophysical parameters taken from Table 1.
Figure 3a,b show the measured [3O2] and [S0] at just below the surface (d = 0) versus time in
an Intralipid phantom (with µs’ = 0.2 cm−1) for three different initial Photofrin concentrations (27, 50,
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167 mM). The symbols are measured values and the lines are SOED-calculated results. Figure 3c
shows the PS photobleaching rate per PDT dose, − d[S0]dt 1[S0]φ[3O2]/([3O2]+β) versus [S0]. The symbols are
calculated values using Equation (7), and the line is the best linear fit. Figure 3d shows the expected
SOED-calculated cumulative reacted singlet oxygen concentration, [1O2]rx, during illumination.
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Figure 3. Comparison of measured and singlet oxygen explicit dosimetry (SOED)-calculated values
of (a) [3O2](t) and (b) [S0](t) at d = 0 for three initial photosensitizer concentrations, [S0]0 = 27, 50,
167 µM. Measurements of ground-state oxygen were made at 5–30 s intervals, while photosensitizer
spectra were obtained every 10 s. The average initial [3O2]0 value was 160.4 µM. (c) The left-hand side
of Equation (7) versus the Photofrin concentration, with the line of best fit. The slope of the fit was
(6.86 ± 0.6) × 10−7 mM·s−1·mW−1·cm2 and the intercept was (1.78 ± 0.25) × 10−5 s−1·mW−1·cm2,
resulting in a value of δ = 25 ± 4.3 µM. (d) Calculated volume-averaged [1O2]rx over time. The light
fluence rates used in the experiment were φ0 = 45, 38, and 42 mW/cm2 for each sensitizer concentration.
The symbols are measured values in Figure 3a,b and are calculated values using Equation (7) for
Figure 3c. The lines are SOED-calculated results for Figure 3a,b,d, and the line of best fit for Figure 3c.
3.3. SOED/SOLD Comparison in Solution
The singlet oxygen generated in Photofrin-containing solutions was calculated using SOED and
the results were compared to SOLD-determined luminescence counts of 1O2. The latter was correlated
with the amount of 1O2 produced instantaneously and cumulatively. Instantaneous [1O2] accounts for
the singlet oxygen generated for each pulse of laser excitation, while cumulative [1O2]rx is the integral
of all singlet oxygen produced during the entire illumination time over the entire illumination volume.
The agreement between the two methods (SOED and SOLD) is shown in Figure 4: (a) shows SOLD
counts per accumulation time (in seconds, t = 300 s before and after PDT) and (b) shows cumulative
SOLD counts over the entire treatment time of 900 s. Photofrin was dissolved in MeOH solution.
Cancers 2016, 8, 109 8 of 15Cancers 2016, 8, 109 8 of 15 
 
 
Figure 4. (a) Comparison of SOLD-obtained 1O2 counts (Equation (8)) per accumulation time (in 
seconds) at 523 nm and SOED-calculated instantaneous [1O2] (Equation (1)) for Photofrin 
concentrations in MeOH of 17, 50, and 83 µM, and light fluence φ0 = 30 mW/cm2. The initial oxygen 
concentration was measured as 175 ± 6 µM. (b) Comparison of SOLD cumulative 1O2 counts (Equation 
(9)) and reacted singlet oxygen concentration ([1O2]rx) calculated with SOED (Equation (4)) for 
Photofrin concentration of 17, 50, and 83 µM. PDT was performed with 523 nm light at φ0 = 30 mW/cm2 
for 900 s. 
4. Discussion 
4.1. SOED and SOLD Intercomparison 
The SOED calculated [1O2] value in solution in Figure 4a corresponded to the volumetric 
averaged instantaneous singlet oxygen concentration over a volume of 1 cm depth and 1 cm2 area. 
SOED-calculated [1O2]rx in Figure 4b corresponded to the volumetric average reacted singlet oxygen 
concentration of the same 1 cm3 volume. In these solutions, the light fluence was calculated by 
introducing attenuation that was only due to the photosensitizer absorption, since no scatterer was 
added and solutions were of pure Photofrin: φ = φ0 exp(−μa × d), where φ0 is the light fluence rate 
(mW/cm2) measured directly in the back of the front wall of the solution facing the laser. Absorption 
coefficients (μa) were 0.15, 0.45, and 0.74 cm−1 for Photofrin concentrations of 17, 50, and 83 mM, 
respectively, at 523 nm. 
In order to experimentally determine the photophysical parameters of the spontaneous 
phosphorescence rate of 1O2 to 3O2 (k6) and the bimolecular reaction rate of 1O2 with the substrate (k7) 
in Photofrin phantoms, photosensitizer triplet-state and singlet oxygen lifetime measurements were 
obtained using the SOLD system. Varying amounts of the singlet oxygen quencher, sodium azide 
(NaN3), were added to the Photofrin–MeOH solutions. The resulting fits to obtain k6 and k7 are shown 
in Figure 2. For Photofrin with NaN3, k6 was found to be 1.14 × 105 s−1 (the intercept of the line of best 
fit in Figure 2) and k7 was found to be 235 µM−1·s−1 (the slope of the line of best fit in Figure 2). k7 is 
pH-dependent, but is in the range of the reported value of 300–400 µM−1·s−1 for the quenching rate 
constant in water [38]. These values were used to calculate τ∆ for the in vitro condition (without NaN3) 
and the in vivo condition (taken from the literature for biological tissue [34]). Assuming that k7 for 
NaN3 is greater than or equal to that of in vivo conditions (assuming biological tissue is less efficient 
than NaN3 in quenching 1O2), it can be estimated that in vivo acceptor concentration [A] ≥ 107 (s−1)/235 
mM−1·s−1 = 42 mM. This value is much higher than [A] = 0.83 mM in the literature [10], but we feel that 
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Figure 4. (a) Comparison of SOLD-obtained 1O2 counts (Equation (8)) per accumulation time
(in seconds) at 523 nm and SOED-calculated instantaneous [1O2] (Equation (1)) for Photofrin concentrations
in MeOH of 17, 50, and 83 µM, and light fluence φ0 = 30 mW/cm2. The initial oxygen concentration was
measured as 175 ± 6 µM. (b) Comparison of SOLD cumulative 1O2 counts (Equation (9)) and reacted
singlet oxygen concentration ([1O2]rx) calculated with SOED (Equation (4)) for Photofrin concentration
of 17, 50, and 83 µM. PDT was performed with 523 nm light at φ0 = 30 mW/cm2 for 900 s.
4. Discussion
4.1. SOED and SOLD Intercomparison
The SOED calculated [1O2] value in solution in Figure 4a corresponded to the volumetric
averaged instantaneous singlet oxygen concentration over a volume of 1 cm depth and 1 cm2 area.
SOED-calculated [1O2]rx in Figure 4b corresponded to the volumetric average reacted singlet oxygen
concentration of the same 1 cm3 volume. In these solutions, the light fluence was calculated by
introducing attenuation that was only due to the photosensitizer absorption, since no scatterer was
added and solutions were of pure Photofrin: φ = φ0 exp(−µa × d), where φ0 is the light fluence rate
(mW/cm2) measured directly in the back of the front wall of the solution facing the laser. Absorption
coefficients (µa) were 0.15, 0.45, and 0.74 cm−1 for Photofrin concentrations of 17, 50, and 83 mM,
respectively, at 523 nm.
In order to experimentally determine the photophysical parameters of the spontaneous
phosphorescence rate of 1O2 to 3O2 (k6) and the bimolecular reaction rate of 1O2 with the substrate
(k7) in Photofrin phantoms, photosensitizer triplet-state and singlet oxygen lifetime measurements
were obtained using the SOLD system. Varying amounts of the singlet oxygen quencher, sodium azide
(NaN3), were added to the Photofrin–MeOH solutions. The resulting fits to obtain k6 and k7 are shown
in Figure 2. For Photofrin with NaN3, k6 was found to be 1.14 × 105 s−1 (the intercept of the line of
best fit in Figure 2) and k7 was found to be 235 µM−1·s−1 (the slope of the line of best fit in Figure 2).
k7 is pH-dependent, but is in the range of the reported value of 300–400 µM−1·s−1 for the quenching
rate constant in water [38]. These values were used to calculate τ∆ for the in vitro condition (without
NaN3) and the in vivo condition (taken from the literature for biological tissue [34]). Assuming that
k7 for NaN3 is greater than or equal to that of in vivo conditions (assuming biological tissue is
less efficient than NaN3 in quenching 1O2), it can be estimated that in vivo acceptor concentration
[A] ≥ 107 (s−1)/235 mM−1·s−1 = 42 mM. This value is much higher than [A] = 0.83 mM in the
literature [10], but we feel that it is more reasonable since the singlet oxygen lifetime in vivo, τ∆,
does not change for reacted singlet oxygen concentrations [1O2]rx as high as 12 mM [16], indicating
there are still plenty of acceptors in vivo at this level.
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The light fluence rate distribution in a semi-infinite medium as a function of distance (d) was
calculated by a Monte Carlo (MC) simulation [39] of a circular parallel beam (diameter 0.8 cm, Figure 5a)
and broad beam (diameter 16 cm, Figure 5b) for absorption coefficient (µa) of 0.09, 0.18, and 0.58 cm−1,
and reduced scattering coefficient (µs’) of 0.2 cm−1. The resulting φ/φ0 is shown in Figure 5 along with
an exponential fit based on µa. For the tissue-simulating phantoms with Photofrin shown in Figure 3,
φ0 is the measured local fluence rate at the front inner surface of the phantom facing the laser and d is
the depth from surface. At 630 nm, µa = 0.09, 0.18, and 0.58 cm−1 for Photofrin concentrations of 27, 50,
and 167 mM, respectively. It is clear that the function e−µad, while working well for the broad beam,
does not work very well for the 0.8 cm diameter beam at the deepest depths investigated. As a result,
MC-generated light fluence rate φ/φ0 was used directly for the SOED calculations in phantom.
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Figure 5. Monte Carlo (MC) simulation of fluence rate distribution by a circular beam of radius
(a) 0.4 cm and (b) 8 cm incident on a semi-infinite liquid surface as a function of depth (d) for µa = 0.09,
0.18, and 0.58 cm−1 and µs’ = 0.2 cm−1. Fits of exponential forms are shown along with the MC data.
The exponential form of e−µad fits the simulation well up to a depth of 0.4 cm, while overestimating
φ/φ0 at larger depths. Broad-beam simulations agree with the simple exponential form up to a depth
of 1.3 cm.
SOED calculations of singlet oxygen concentration are highly dependent on the photophysical
parameters used as input (Table 1). In turn, these para eters depend on the photosensitizer used,
as well as the treatment environment. The necessary parameters for Photofrin-mediated PDT for
in vitro studies were validated with explicit measurements of the [3O2] and [S0]. In particular,
the consumption rate of [S0] per PDT dose was used to determine a more accurate value of σ
(slope/ξ) and δ (intercept/slope) for the experimental setup used (Figure 3c and Equation (7)).
This was used to determine δ and σ using a method from Reference [40] that is also described in
Section 2.1. Photosensitizer concentration was measured over time to determine the photobleaching
rate (−d[S0]/dt) and [S0]. Along with the measured [3O2], the PS photobleaching rate per PDT dose
can be calculated and plotted as in Figure 3c. The slope and intercept of the fit to the data are used
to calculate δ and σ. The value for ξ in vitro was calculated by the definition of ξ provided in Table 1.
The resulting values were δ = 25 ± 4.3 µM and σ = (6.6 ± 7) × 10−5 µM−1. The value of β was set to be
11.9 µM for this set of experiments [34]. Figure 3a,b show the SOED calculations using Equations (2)
and (3), which agree with [3O2](t) and [S0](t) measurements at surface (d = 0 cm) of the Intralipid
phantom. Figure 3d shows the magnitude of SOED-calculated [1O2]rx using Equation (4) for Photofrin
to be in the mM range.
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It can be concluded from the intercomparison of SOED and SOLD in Photofrin solutions (Figure 5b)
that the cumulative SOLD [1O2] counts, [SOLD], and SOED-calculated [1O2]rx values track each other
very well (R2 = 0.98) for Photofrin, with a conversion factor of the following form:
[1O2]rx(mM) =
(
2.16× 10−5
)
× [SOLD]− 11.8 (10)
The ratio of slopes between the two panels ((a) and (b)) in Figure 4 is 9.6 × 10−6 s, which is
consistent with the value of τ∆ obtained (9.4 × 10−6 s). The reason for the intercept is not known,
and a linear fit without intercept reduces the correlation (R2 = 0.86). The good correlation of
SOED-calculated [1O2] and [SOLD] demonstrates that SOED can be utilized in scenarios where
direct phosphorescence measurement of 1O2 is difficult.
4.2. Feasibility of Using SOLD at 523 nm for Predicting [1O2]rx at 630 nm
Currently, the only available pulsed laser suitable for the SOLD application (CrystaLaser,
QL-523-200-S, CrystaLaser, Reno, NV, USA) is at 523 nm. As a result, the effective tissue-sampling depth
for [1O2] is not the same as that of the 630 nm treatment light used clinically with Photofrin. Figure 6
shows the measured values µa and µs’ in various sites measured in vivo in patients, including the
anterior chest wall, apex of the heart (apex), posterior chest wall, diaphragm (diaph), serratus (ser),
anterior sulcus, posterior sulcus, pericardium (peri), and normal (norm) tissue. Patients were
undergoing an institutional review board (IRB)-approved pleural mesothelioma Photofrin-PDT
clinical protocol at the University of Pennsylvania. These optical properties were measured using
a custom-built multifiber contact probe for absorption spectroscopy [27]. The measured optical
properties include µa and µs’ for tissue as well as Photofrin.
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mean optical properties of μa = 5.52 cm−1 and μs’ = 17.61 cm−1 for 523 nm and μa = 0.58 cm−1and μs’ = 
15.61 cm−1 for 630 nm. As expected, the optical penetration is much deeper at 630 nm than at 523 nm 
in in vivo malignant pleural mesothelioma (MPM) patients. 
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with the upper and lower bounds of the tissue optical properties obtained in vivo as dark blue and
light blue, respectively. The dashed black lines show the calculated light fluence distribution using the
ean optical properties of µa = 5.52 c 1 and µs’ = 17.61 cm−1 for 523 nm and µa = 0.58 cm−1 and
µs’ = 15.61 cm−1 for 630 nm. As xpected, the optical penetration is much deeper at 630 nm than at
523 nm in in vivo malignant pl ural mesothelioma (MPM) patients.
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Figure 7. The ratio of φ and in-air fluence rate (φair) versus tumor depth for (a) 523 nm and (b) 630 nm
optically broad laser beams on an air–tissue interface using an analytical formula that fits MC
simulation [29–32] and optical properties obtained in in vivo MPM patients (Figure 4).
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[1 2]rx for 630 and 523 nm is show in Figure 8. µa ranges from 0.66 to 23.1 cm−1 at 523 nm and
0.17 to 1.35 cm−1 at 630 nm, while µ ’ ranges from 2.80 to 73.7 cm−1 at 523 nm and 2.55 to 30.5 cm−1 at
630 nm (Figure 6). In order to investigate the effects of different φ on the [1O2]rx, the SOED calculations
were repeated for φ = 5, 25, 50, 75, and 150 mW/cm2. Different colors of symbols represent different
φ. The black solid lines are the best fits in Figure 8b. At 523 nm, the range of [1O2]rx changed from
0–0.1, 0–0.63, and 0–5.6 mM for PS concentrations of 0.21, 2.1, and 21 µM, respectively, while the
range of [1O2]rx at 630 nm changed from 0–0.25, 0–2.5, and 0–20 mM, respectively, for the same
PS concentrations.
The resulting correspondence for a range of PS concentrations (c) of 0.21, 2.1, and 20.1 mM (based on
the average Photofrin concentration obtained in patients) and light fluence of 10–120 J/cm2 [33] can be
expressed as:
[1O2]rx(630 nm) = a(c)[
1O2]rx(523 nm) + b(c, φ) (11)
where
a(c) = 0.05814c+ 1.922 (12)
and
b(c, φ) = (0.000618c− 0.000033)φ (13)
where c is the PS concentration (in µM) and φ is the light fluence (in J/cm2). We thus conclude that
SOLD measurement at 532 nm can be used to monitor [1O2]rx at 630 nm if a conversion formula
(Equations (11)–(13)) is used to convert the measured SOLD signal.
When SOLD signal from patients are used to determine the generation of singlet oxygen, it is
important to develop a tissue optical properties correction factor to account for the absorption and
scattering of luminescence by tissue, similar to the optical properties correction factor needed for using
fluorescence to determine the PS concentration [14]. This is beyond the scope of this paper.
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5. Conclusions
Direct singlet oxygen luminescence dosimetry (SOLD) measurements were compared with
singlet oxygen explicit dosimetry (SOED) calculations for phantoms using Photofrin. Oxygen and
PS concentration measurements were compared with SOED predictions to validate the SOED model
and to obtain the photophysical parameters (Table 1, δ = 25 ± 4.3 µM and σ = (6.6 ± 7) × 10−5 µM−1
in vitro). Using lifetime measurements obtained with the SOLD system, photophysical parameters
k6 (1.14 × 10−5 s−1) and k7 (235 µM−1·s−1) were found for in vitro solutions with NaN3. A linear
relationship between SOLD singlet oxygen photon counts at 1270 nm and SOED-calculated reacted
singlet oxygen (Equation (10)) was established for Photofrin for 523 nm light excitation. Based on our
SOED calculations, a formula (Equations (11)–(13)) for converting cumulative SOLD signal measured
at 523 nm to the corresponding [1O2]rx at 630 nm was established using the optical properties at the
two wavelengths in an ongoing MPM clinical protocol.
These results indicate that, with suitable correction for the tissue optical properties at the
two wavelengths, there is excellent correlation between the direct (SOLD) and indirect (SOED)
estimates of the singlet oxyge generated during PDT. Since, at the present time, the SOED a roach
is technically simpler and the in trumentation is significantly less xpensive, t is validation supports
its us in clin cal dosimetry. It should be n ted, however, that the SOLD te hnique is intrinsically
more robust in that no simplifying assumptio s are requi ed as in SOED. Hence, care must be taken
in applying SOED to ensure that the reatment parameters lie within the range of valid y of these
a sumptions. Furthermore, the validation of SOED must be carried out for ach phot sensit z and set
of clinical conditions. In th futur , with de opments such as our recent report of fiber ptic-coupled
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SOLD techniques based on novel superconducting nanowire single-photon detector technologies of
direct SOLD, which currently can be considered as the laboratory Gold Standard for PDT dosimetry,
may accelerate movement towards clinical utilization of SOLD alongside SOED. For type I PDT with
photosensitizers, where a reactive oxygen species (e.g., oxygen radicals) other than singlet oxygen is the
main cytotoxic agent, it is still possible to model the photophysical process using SOED, as described
in a recent review [19]. However, it remains a challenge to find the value of photophysical parameters
needed to describe the type I interactions for those photosensitizers.
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